Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Recombinant coagulation factor VIIa, Acset |
Is a |
False |
Eptacog alfa (substance) |
Inferred relationship |
Some |
|
facteur VIIa de coagulation recombinant 60 000 U.I., fiole de poudre et solvant pour solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Eptacog alfa (substance) |
Inferred relationship |
Some |
|
facteur VIIa de coagulation recombinant 120 000 U.I., fiole de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Eptacog alfa (substance) |
Inferred relationship |
Some |
|
facteur VIIa de coagulation recombinant 240 000 U.I., fiole de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Eptacog alfa (substance) |
Inferred relationship |
Some |
|
Product containing eptacog alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Eptacog alfa (substance) |
Inferred relationship |
Some |
1 |
Recombinant coagulation factor VIIa 60,000iu powder for conventional release solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Eptacog alfa (substance) |
Inferred relationship |
Some |
|
Recombinant coagulation factor VIIa 240,000iu powder for conventional release solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Eptacog alfa (substance) |
Inferred relationship |
Some |
|
Recombinant coagulation factor VIIa 120,000iu powder for conventional release solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Eptacog alfa (substance) |
Inferred relationship |
Some |
|
Eptacog alfa only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Eptacog alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely eptacog alfa 1 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Eptacog alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely eptacog alfa 1 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Eptacog alfa (substance) |
Inferred relationship |
Some |
1 |
Eptacog alfa-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Eptacog alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing only eptacog alfa in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Eptacog alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely eptacog alfa 2 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Eptacog alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely eptacog alfa 2 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Eptacog alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely eptacog alfa 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Eptacog alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely eptacog alfa 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Eptacog alfa (substance) |
Inferred relationship |
Some |
1 |
Eptacog alfa 8 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Eptacog alfa (substance) |
Inferred relationship |
Some |
1 |
Eptacog alfa 8 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Eptacog alfa (substance) |
Inferred relationship |
Some |
1 |